lentiviral gene therapy ( Genethon/Institute of Child Health, London/Imagine Institute)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namelentiviral gene therapy ( Genethon/Institute of Child Health, London/Imagine Institute)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionIL-2RG gene transference
TargetsInterleukin-2 receptor subunit gamma
Therapy Area/IndicationsSevere Combined Immunodeficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenethon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenethon
Active IndicationsN/A
Inactive IndicationsSevere Combined Immunodeficiency

Other Information

ATC CodeN/A
Related LinksN/A